ESOMEPRAZOL IN TREATMENT OF GASTROESOPHAGIAL REFLUX DISEASE IN CHILDREN AND ADOLESCENTS

ESOMEPRAZOL IN TREATMENT OF GASTROESOPHAGIAL REFLUX DISEASE IN CHILDREN AND ADOLESCENTS

Show other versions (1)

The results of trials of activity of esomeprazol in children with gastroesophagial reflux disease (gerd) are presented in this article. It was marked that esomeprazol (Nexium) can be used in children of 1–11 years (10 or 20 mg daily) and 12–17 years (20 or 40 mg daily) with gerd according to modern...

ver descrição completa

Detalhes bibliográficos
Autor principal:	R.T. Saygitov
Formato:	Artigo
Idioma:	English
Publicado em:	"Paediatrician" Publishers LLC 2008-08-01
Colecção:	Вопросы современной педиатрии
Acesso em linha:	https://vsp.spr-journal.ru/jour/article/view/1441

Registos relacionados

ESOMEPRAZOL IN TREATMENT OF GASTROESOPHAGIAL REFLUX DISEASE IN CHILDREN AND ADOLESCENTS
Por: R.T. Saygitov
Publicado em: (2008-01-01)

Clinical utility of esomeprazole for treatment of gastroesophageal reflux disease in pediatric and adolescent patients
Por: Cardile S, et al.
Publicado em: (2012-02-01)

Efficacy of esomeprazole at treatment of patients with gastroesophageal reflux disease
Por: Yu. V. Yevsyutina
Publicado em: (2018-08-01)

Effects of esomeprazole treatment for gastroesophageal reflux disease on quality of life in 12- to 17-year-old adolescents: an international health outcomes study
Por: Gold Benjamin D, et al.
Publicado em: (2009-11-01)

Relationship between esomeprazole dose and timing to heartburn resolution in selected patients with gastroesophageal reflux disease
Por: Roy C Orlando, et al.
Publicado em: (2010-09-01)

Managing peptic ulcer and gastroesophageal reflux disease in elderly Chinese patients – focus on esomeprazole
Por: Tang RS, et al.
Publicado em: (2013-10-01)

Comparison of the Effect of Omeprazole, Pantoprazole, Esomeprazole, and Lansoprazole on the Reduction of Symptoms in Patients with Gastroesophageal Reflux Disease
Por: Nima Arezoomandi, et al.
Publicado em: (2019-02-01)

The influence of demographic factors and health-related quality of life on treatment satisfaction in patients with gastroesophageal reflux disease treated with esomeprazole
Por: El-Dika Samer, et al.
Publicado em: (2005-01-01)

Induced Sputum Substance P in Children with Difficult-to-Treat Bronchial Asthma and Gastroesophageal Reflux: Effect of Esomeprazole Therapy
Por: Adel Salah Bediwy, et al.
Publicado em: (2011-01-01)

The Benefits of Combination Therapy with Esomeprazole and Rebamipide in Symptom Improvement in Reflux Esophagitis: An International Multicenter Study
Por: Su Jin Hong, et al.
Publicado em: (2016-11-01)

EFFICACY OF IBUPROFEN IN TREATMENT OF PAIN IN CHILDREN: SYSTEMATIC REVIEW OF RANDOMIZED CONTROLLED STUDIES
Por: R.T. Saygitov
Publicado em: (2010-11-01)

EFFICACY OF IBUPROFEN IN TREATMENT OF PAIN IN CHILDREN: SYSTEMATIC REVIEW OF RANDOMIZED CONTROLLED STUDIES
Por: R.T. Saygitov
Publicado em: (2010-01-01)

Efficacy and Safety of Dual Delayed-Release Formulation of Esomeprazole in Patients with Gastroesophageal Reflux Disease: A Multicenter, Prospective, Observational Study
Por: Hyun Lim, et al.
Publicado em: (2025-01-01)

IMPROVEMENT OF QUALITY OF LIFE AS THE MAIN OBJECTIVE OF ALLERGIC RHINITIS THERAPY IN CHILDREN
Por: R.T. Saygitov
Publicado em: (2008-04-01)

DIFFERENTIATED («SEASON») APPROACH TO THE PROPHYLAXIS OF VITAMIN D3 INSUFFICIENCY IN CHILDREN
Por: R.T. Saygitov
Publicado em: (2009-09-01)

IMPROVEMENT OF QUALITY OF LIFE AS THE MAIN OBJECTIVE OF ALLERGIC RHINITIS THERAPY IN CHILDREN
Por: R.T. Saygitov
Publicado em: (2008-01-01)

DIFFERENTIATED («SEASON») APPROACH TO THE PROPHYLAXIS OF VITAMIN D3 INSUFFICIENCY IN CHILDREN
Por: R.T. Saygitov
Publicado em: (2009-01-01)

ESOMEPRAZOLE EFFICACY IN TREATMENT OF THE INFLAMMATORY DISEASES OF THE UPPER GASTROINTESTINAL TRACT AMONG CHILDREN, SUFFERING FROM RHEUMATIC DISEASES
Por: E.I. Alexeeva, et al.
Publicado em: (2007-01-01)

ESOMEPRAZOLE EFFICACY IN TREATMENT OF THE INFLAMMATORY DISEASES OF THE UPPER GASTROINTESTINAL TRACT AMONG CHILDREN, SUFFERING FROM RHEUMATIC DISEASES
Por: E.I. Alexeeva, et al.
Publicado em: (2007-01-01)

MICRONUTRIENTS AND CHILDREN'S PHYSICAL GROWTH: A META ANALYSIS OF RANDOMIZED CONTROLLED TRIALS
Por: R.T. Saygitov
Publicado em: (2008-06-01)

MICRONUTRIENTS AND CHILDREN'S PHYSICAL GROWTH: A META ANALYSIS OF RANDOMIZED CONTROLLED TRIALS
Por: R.T. Saygitov
Publicado em: (2008-01-01)

Esomeprazole-induced lichen planus
Por: Miguel Santos-Coelho, et al.
Publicado em: (2023-04-01)

REGULAR USE OF MILK AND DAIRY PRODUCTS, AND ITS INFLUENCE ON BONE MINERAL DENSITY IN CHILDREN: SYSTEMATIC REVIEW
Por: R.T. Saygitov
Publicado em: (2008-12-01)

REGULAR USE OF MILK AND DAIRY PRODUCTS, AND ITS INFLUENCE ON BONE MINERAL DENSITY IN CHILDREN: SYSTEMATIC REVIEW
Por: R.T. Saygitov
Publicado em: (2008-01-01)

DESLORATADINE IN TREATMENT OF ALLERGIC RHINITIS: RESULTS OF RANDOMIZED, PLACEBO_CONTROLLED TRIAL
Por: R.T. Saygitov
Publicado em: (2008-01-01)

DESLORATADINE IN TREATMENT OF ALLERGIC RHINITIS: RESULTS OF RANDOMIZED, PLACEBO_CONTROLLED TRIAL
Por: R.T. Saygitov
Publicado em: (2008-01-01)

INCREASE OF BODY WEIGHT IN CHILDREN AS A RESULT OF ADMINISTRATION OF MICRONUTRIENTS CONTAINING VITAMIN A: THE RESULTS OF PLACEBO-CONTROLLED STUDIES
Por: R.T. Saygitov
Publicado em: (2008-10-01)

INCREASE OF BODY WEIGHT IN CHILDREN AS A RESULT OF ADMINISTRATION OF MICRONUTRIENTS CONTAINING VITAMIN A: THE RESULTS OF PLACEBO-CONTROLLED STUDIES
Por: R.T. Saygitov
Publicado em: (2008-01-01)

Preclinical Evaluation of Esomeprazole Safety and Toxicokinetics
Por: V. M. Kosman, et al.
Publicado em: (2023-06-01)

Safety aspects and rational use of a naproxen + esomeprazole combination in the treatment of rheumatoid disease
Por: David N Roberts, et al.
Publicado em: (2011-03-01)

Efficacy of esomeprazole in treating acid-related diseases in Japanese populations
Por: Furuta T, et al.
Publicado em: (2012-05-01)

Therapeutic Response to 20 mg of Esomeprazole Twice Daily in Patients with Gastroesophageal Reflux Disease-related Non-cardiac Chest Pain: An Open-Label Randomized Pilot Study
Por: Jae Kyun Choi, et al.
Publicado em: (2020-06-01)

Crystallization of Esomeprazole Magnesium Water/Butanol Solvate
Por: Jenna Skieneh, et al.
Publicado em: (2016-04-01)

Esomeprazole: a Safe Alternative to Lansoprazole Allergy?
Por: Muammer Kara, et al.
Publicado em: (2014-08-01)

Esomeprazole and apixaban pharmacokinetic interactions in healthy rats
Por: Ali Jaber, et al.
Publicado em: (2022-10-01)

Diagnosis and Treatment of Gastroesophageal Reflux Disease in Infants and Children
Por: Yvan Vandenplas
Publicado em: (2000-01-01)

MELATONIN IN COMPLEX TREATMENT OF GASTROESOPHAGEAL REFLUX DISEASE IN CHILDREN
Por: O. V. Syresina, et al.
Publicado em: (2012-02-01)

The pharmacokinetics and pharmacodynamics of esomeprazole in sheep after intravenous dosing
Por: Joe S. Smith, et al.
Publicado em: (2023-05-01)

Effect of esomeprazole on lipid profile in patients with peptic ulcer
Por: Eman Abdullah, et al.
Publicado em: (2021-08-01)

EFFECTIVENESS OF EDITING IN PREPARATION OF ORIGINAL ARTICLES: RESULTS OF RANDOMIZED CONTROLLED STUDY
Por: R.T. Saygitov
Publicado em: (2010-11-01)